Lung Cancer Trials Ask AI to find trials
Active Not RecruitingNot applicableNCT06004440
Official study title

Real World Registry for Use of the Ion Endoluminal System

Study summary

The primary objective of this study is to evaluate the performance of the Ion Endoluminal System with real-world use for pulmonary lesion localization or biopsy.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedIon Endoluminal System

The study team can explain what participation involves.

Who it may be forLung Cancer · Multiple Pulmonary Nodules

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Apr 24, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Active Not Recruiting

The study is underway but is not accepting new participants.

What kind of study?Not applicable

Observational

Where is it offered?16 U.S. locations

Locations may change over time.

Who runs it?Intuitive Surgical

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Intuitive Surgical
Interventions being studied
Device: Ion Endoluminal System
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Subject is 18 years or older at the time of the index procedure.
  • Subject is a candidate for an elective, planned lung lesion localization or biopsy procedure utilizing the Ion Endoluminal System.
  • Subject able to understand and adhere to study requirements and provide informed consent.
Reasons someone may not be able to joinExclusion criteria
  • Subject is under the care of a Legally Authorized Representative (LAR) and is unable to provide informed consent on their own accord.
  • Subject is participating in an interventional research study or research study investigational agents with an unknown safety profile that would interfere with participation in this study.
  • Female subjects who are pregnant or nursing at the time of the index bronchoscopy procedure, as determined by standard site practices.
  • Subjects that are incarcerated or institutionalized under court order, or other vulnerable populations.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Orlando Health Orlando Regional Medical CenterOrlando, Florida
  • Ascension Alexian BrothersElk Grove Village, Illinois
  • Blessing HospitalQuincy, Illinois
  • Kansas University Medical CenterKansas City, Kansas
  • Tulane UniversityNew Orleans, Louisiana
  • Henry Ford HospitalDetroit, Michigan
  • Mayo ClinicRochester, Minnesota
  • Mercy Hospital of BuffaloBuffalo, New York
  • Atrium Health of the CarolinasCharlotte, North Carolina
  • Cone Health Moses Cone Memorial HospitalGreensboro, North Carolina
  • FirstHealth Moore Regional HospitalPinehurst, North Carolina
  • Ohio State University Wexner Medical CenterColumbus, Ohio

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 24, 2026. Always confirm current availability with the study team.

View original record ↗